|
|
|
Volumn 6, Issue 7, 2007, Pages 757-760
|
|
A brief primer on treatments of cutaneous T cell lymphoma, newly approved or late in development.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BEXAROTENE;
DENILEUKIN DIFTITOX;
DIPHTHERIA TOXIN;
HYBRID PROTEIN;
HYDROXAMIC ACID;
INTERLEUKIN 2;
MONOCLONAL ANTIBODY;
TETRALIN DERIVATIVE;
VORINOSTAT;
ZANOLIMUMAB;
CUTANEOUS T CELL LYMPHOMA;
DRUG APPROVAL;
HUMAN;
MYCOSIS FUNGOIDES;
REVIEW;
SKIN TUMOR;
TREATMENT OUTCOME;
ANTIBODIES, MONOCLONAL;
DIPHTHERIA TOXIN;
DRUG APPROVAL;
HUMANS;
HYDROXAMIC ACIDS;
INTERLEUKIN-2;
LYMPHOMA, T-CELL, CUTANEOUS;
MYCOSIS FUNGOIDES;
RECOMBINANT FUSION PROTEINS;
SKIN NEOPLASMS;
TETRAHYDRONAPHTHALENES;
TREATMENT OUTCOME;
|
|
EID: 34548839641
PISSN: 15459616
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (6)
|
|
References (18)
|
